MOP114893/Canadian Institutes of Health Research/Canada[Grant Number] - Search Results

Year	Number of Results
2012	2
2013	6
2014	6
2015	5
2016	1
2022	0

1

Basic mechanisms of calcific aortic valve disease.

Mathieu P, Boulanger MC. Mathieu P, et al. Can J Cardiol. 2014 Sep;30(9):982-93. doi: 10.1016/j.cjca.2014.03.029. Epub 2014 Mar 27. Can J Cardiol. 2014. PMID: 25085215 Review.

2

Innate and Adaptive Immunity in Calcific Aortic Valve Disease.

Mathieu P, Bouchareb R, Boulanger MC. Mathieu P, et al. J Immunol Res. 2015;2015:851945. doi: 10.1155/2015/851945. Epub 2015 May 3. J Immunol Res. 2015. PMID: 26065007 Free PMC article. Review.

3

Ectopic visceral fat: a clinical and molecular perspective on the cardiometabolic risk.

Mathieu P, Boulanger MC, Després JP. Mathieu P, et al. Rev Endocr Metab Disord. 2014 Dec;15(4):289-98. doi: 10.1007/s11154-014-9299-3. Rev Endocr Metab Disord. 2014. PMID: 25326657 Review.

4

Molecular biology of calcific aortic valve disease: towards new pharmacological therapies.

Mathieu P, Boulanger MC, Bouchareb R. Mathieu P, et al. Expert Rev Cardiovasc Ther. 2014 Jul;12(7):851-62. doi: 10.1586/14779072.2014.923756. Epub 2014 May 24. Expert Rev Cardiovasc Ther. 2014. PMID: 24857537 Review.

5

Inflammation is associated with the remodeling of calcific aortic valve disease.

Coté N, Mahmut A, Bosse Y, Couture C, Pagé S, Trahan S, Boulanger MC, Fournier D, Pibarot P, Mathieu P. Coté N, et al. Inflammation. 2013 Jun;36(3):573-81. doi: 10.1007/s10753-012-9579-6. Inflammation. 2013. PMID: 23225202

6

Adenosine derived from ecto-nucleotidases in calcific aortic valve disease promotes mineralization through A2a adenosine receptor.

Mahmut A, Boulanger MC, Bouchareb R, Hadji F, Mathieu P. Mahmut A, et al. Cardiovasc Res. 2015 Apr 1;106(1):109-20. doi: 10.1093/cvr/cvv027. Epub 2015 Feb 2. Cardiovasc Res. 2015. PMID: 25644539

7

Lipoprotein lipase in aortic valve stenosis is associated with lipid retention and remodelling.

Mahmut A, Boulanger MC, Fournier D, Couture C, Trahan S, Pagé S, Arsenault B, Després JP, Pibarot P, Mathieu P. Mahmut A, et al. Eur J Clin Invest. 2013 Jun;43(6):570-8. doi: 10.1111/eci.12081. Epub 2013 Apr 1. Eur J Clin Invest. 2013. PMID: 23550604

8

Lp-PLA2 is associated with structural valve degeneration of bioprostheses.

Mahmut A, Mahjoub H, Boulanger MC, Fournier D, Després JP, Pibarot P, Mathieu P. Mahmut A, et al. Eur J Clin Invest. 2014 Feb;44(2):136-45. doi: 10.1111/eci.12199. Epub 2013 Nov 28. Eur J Clin Invest. 2014. PMID: 24328921

9

ATP acts as a survival signal and prevents the mineralization of aortic valve.

Côté N, El Husseini D, Pépin A, Guauque-Olarte S, Ducharme V, Bouchard-Cannon P, Audet A, Fournier D, Gaudreault N, Derbali H, McKee MD, Simard C, Després JP, Pibarot P, Bossé Y, Mathieu P. Côté N, et al. J Mol Cell Cardiol. 2012 May;52(5):1191-202. doi: 10.1016/j.yjmcc.2012.02.003. Epub 2012 Feb 16. J Mol Cell Cardiol. 2012. PMID: 22366713

10

Inhibition of ectonucleotidase with ARL67156 prevents the development of calcific aortic valve disease in warfarin-treated rats.

Côté N, El Husseini D, Pépin A, Bouvet C, Gilbert LA, Audet A, Fournier D, Pibarot P, Moreau P, Mathieu P. Côté N, et al. Eur J Pharmacol. 2012 Aug 15;689(1-3):139-46. doi: 10.1016/j.ejphar.2012.05.016. Epub 2012 May 31. Eur J Pharmacol. 2012. PMID: 22659116

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results